Health Canada’s 2026 Injectable Peptide Warning: What It Means
The April 9, 2026 advisory names common unauthorized injectable peptides, rejects the research-use loophole, and gives Canadians concrete safety steps.
Status checked August 2, 2026The evidence desk
Latest Articles
Evidence explainers, Canadian regulatory notes, and safety reporting from the PeptideInfo Editorial Desk.
How to Read Peptide Research: Cell, Animal and Human Evidence
A study can be real and still fail to answer the question a headline asks. Here is how to separate mechanisms, animal models, associations, trials, and reviews.
Status checked August 2, 2026BPC-157 in Canada: Evidence, Safety and Regulatory Status
BPC-157 is heavily promoted for recovery, but Canadian authorization and human evidence do not support the certainty common in online claims.
Status checked August 2, 2026“For Research Use Only” Does Not Mean Approved for Human Use
Health Canada’s 2026 warning is explicit: research-use labelling is not a safety guarantee or a workaround for unauthorized injectable peptide drugs.
Status checked August 2, 2026How to Check Whether a Drug Is Authorized in Canada
A practical guide to DINs, product monographs, status fields, and the limits of a product-database search.
Status checked August 2, 2026Are Peptides Legal in Canada? How the Rules Actually Work
There is no single yes-or-no legal status for every peptide. The answer depends on the exact product, claim, route, authorization, and activity.
Status checked August 2, 2026What Are Peptides? A Canadian Beginner’s Guide
Peptides are short chains of amino acids - but that simple definition covers natural signals, authorized medicines, supplements, cosmetics, and experimental compounds.
Status checked August 2, 2026Peptides in Canada in 2026: What Is Authorized, What Is Experimental and What Health Canada Is Warning About
Health Canada issued a major warning about unauthorized injectable peptide drugs in 2026. Here is how Canadian authorization works, what current notices say, and why established medicines, clinical trials, and experimental products cannot be treated as one category.
Status checked August 2, 2026